• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.

Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.

View in: PubMed

subject areas
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alemtuzumab
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antilymphocyte Serum
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Humans
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Induction Chemotherapy
  • Kidney Transplantation
  • Logistic Models
  • Male
  • Middle Aged
  • Muromonab-CD3
  • Proportional Hazards Models
  • Recombinant Fusion Proteins
  • Registries
  • Retrospective Studies
  • Treatment Outcome
  • United States
  • Young Adult

authors with profiles
  • Derek A. Dubay
  • Prabhakar K Baliga
  • Vinayak Rohan
  • Satish N. Nadig
  • David J. Taber